MAPK3 and Hypertension: This was further supported by the reduced ROCK activity, reduced oxidative stress and ERK1/2 protein expression along lack of hypertension and cardiovascular–renal remodeling in patients with Bartter’s and Gitelman’s syndromes (Figure 3B) [8].